ArticleJournal of assisted reproduction and genetics2026
Chromosomal abnormalities in primary and secondary recurrent miscarriages: significance for PGT-A.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine the prevalence of embryonic chromosomal abnormalities in patients with recurrent miscarriage (RM) and to assess whether there is a difference between primary and secondary RM.
methodsRetrospective analysis of products of conception (POC) from patients with RM undergoing dilation and curettage. The prevalence of chromosomal aberrations was assessed in 351 POC specimens obtained from 327 patients with a history of three or more pregnancy losses, using quantitative fluorescence polymerase chain reaction (QF-PCR) and chromosomal microarray analysis (CMA). Patients were classified based on their obstetric history: those whose pregnancies all resulted in miscarriage (up to 22 weeks' gestation) without a prior live birth were categorized as having primary RM, whereas all others were classified as secondary RM.
resultsThe overall incidence of embryonic chromosomal abnormalities was 47.6%, occurring in 56.7% of primary RM and 44.1% of secondary RM. A significant positive correlation was found between primary RM and embryonic chromosomal abnormalities (p = 0.008), despite the lower mean maternal age. In the secondary RM subgroup, each additional previous pregnancy which developed beyond 22 weeks significantly reduced the likelihood of embryonic chromosomal abnormalities (p < 0.001).
conclusionPrimary RM patients showed a higher prevalence of embryonic chromosomal abnormalities, despite having a lower maternal age. A history of pregnancies progressing beyond 22 weeks was associated with a reduced likelihood of embryonic chromosomal abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.